Genomic microdiversity of Mycobacterium africanum in Sénégal
9 affiliations
- 1Mycobacteriology Unit, Bacteriology-Virology Laboratory, CHU Aristide Le Dantec Hospital, Dakar, Senegal
- 2Department of Biological and Pharmaceutical Sciences, Faculty of Medicine, Pharmacy and Odontology, Cheikh Anta Diop University, Dakar, Senegal
- 3MEPHI, Aix-Marseille University, Marseille, France
- 4Institut de Recherche en Santé, de Surveillance Épidémiologique et de Formations (IRESSEF), Dakar, Senegal
- 5Assistance Publique-Hôpitaux de Marseille, Marseille, France
- 6Aix-Marseille University, IRD, SSA, MINES, Marseille, France
- 7Aix-Marseille University, SSA, RITMES, Marseille, France
- 8IHU Méditerranée Infection, Marseille, France
- 9Faculty of Health Sciences, Gaston Berger University, Saint-Louis, Senegal
Abstract
Introduction: Mycobacterium africanum is responsible for up to half of tuberculosis cases in West Africa and comprises four sub lineages. Its genomic diversity remains undescribed in Sénégal where M. africanum was first described and where the present study was conducted. Results: Whole Genome Sequencing (WGS) identified one M. africanum lineage L5 isolate and 50 M. africanum lineage L6 isolates, with a predominance of sub lineage L6.1.1 (24/50, 43.7%) across seven of eight regions of Sénégal. The Dakar region gathered all the sub lineages (L5.3, L6.1, L6.1.1, L6.1.3, L6.2.3, L6.3.1, L6.3.2, L6.3.3, unclassified L6), except for sub lineage L6.2. Further Single Nucleotide Polymorphisms (SNPs) analysis revealed substantial genetic diversity among the lineage L6 isolates with mean value of 668.54 (±239.61), while themedian was 465 SNPs (interquartile range = 400, median absolute deviation:163.09). According to the World health Organization Catalogue of mutations in the Mycobacterium tuberculosis complex and their association with drug resistance, WGS predicted antibiotic resistance in 16 strains. Comparing Drug Susceptibility Testing (DST) and WGS results showed complete concordance across 19 DST tested strains. Conclusion: This study highlights the diversity of M. africanum in Sénégal, with intra-lineage genomic variability and predicted antimicrobial resistance. The presence of synonymous mutations in the absence of resistance-associated variants suggests that WGS–based predictions of drug resistance should be interpreted with caution. Author summary: Senegal is the country where Mycobacterium africanum was first described. Mycobacterium africanum is a Mycobacterium tuberculosis complex pathogen responsible for a significant part of tuberculosis cases in some regions in West Africa, including Sénégal. Here whole genome sequencing of 51 M. africanum isolates recovered from eight regions in Sénégal, unprecedently found that one M. africanum lineage 5 isolate and a novel lineage 6 sub lineage, both participated to geographically structure the population of M. africanum in this country. This observation raises questions regarding weight of the multiple determinants of this situation, opening doors for next works aiming to question the zoonotic and environmental contributions.
Related
- Microdiversity drives resilience and niche partitioning in the bloom forming cyanobacteria Limnospira platensis
- Associating Mycobacterium tuberculosis genomic variants with minimum inhibitory concentrations to delamanid and pretomanid
- Comparing subsampling strategies for efficient pairwise analysis of large pathogen genomic and spatial datasets: An application to Mycobacterium tuberculosis transmission
- Diffusion of innovation in family size ideation and acceptability of contraceptive use between migrants and non-migrants in rural Senegal
- Technical efficiency of irrigated rice systems: An empirical study in the Senegal River Valley
BibTeX
@article{diallo2026genomic,
title = {{Genomic microdiversity of Mycobacterium africanum in Sénégal}},
author = {Awa Ba Diallo and Joséphine Badiane and Mamadou Beye and Khardiata Gueye and Sébastien Cortaredona and Seynabou Lo and Michel Drancourt and Ghiles Grine and Makhtar Camara},
journal = {PLOS Neglected Tropical Diseases},
year = {2026},
month = oct,
doi = {10.1371/journal.pntd.0014770},
url = {https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0014770},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Genomic microdiversity of Mycobacterium africanum in Sénégal
AU - Awa Ba Diallo
AU - Joséphine Badiane
AU - Mamadou Beye
AU - Khardiata Gueye
AU - Sébastien Cortaredona
AU - Seynabou Lo
AU - Michel Drancourt
AU - Ghiles Grine
AU - Makhtar Camara
PY - 2026
DA - 2026/10/26
JO - PLOS Neglected Tropical Diseases
DO - 10.1371/journal.pntd.0014770
UR - https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0014770
AB - Introduction: Mycobacterium africanum is responsible for up to half of tuberculosis cases in West Africa and comprises four sub lineages. Its genomic diversity remains undescribed in Sénégal where M. africanum was first described and where the present study was conducted. Results: Whole Genome Sequencing (WGS) identified one M. africanum lineage L5 isolate and 50 M. africanum lineage L6 isolates, with a predominance of sub lineage L6.1.1 (24/50, 43.7%) across seven of eight regions of Sénégal. The Dakar region gathered all the sub lineages (L5.3, L6.1, L6.1.1, L6.1.3, L6.2.3, L6.3.1, L6.3.2, L6.3.3, unclassified L6), except for sub lineage L6.2. Further Single Nucleotide Polymorphisms (SNPs) analysis revealed substantial genetic diversity among the lineage L6 isolates with mean value of 668.54 (±239.61), while themedian was 465 SNPs (interquartile range = 400, median absolute deviation:163.09). According to the World health Organization Catalogue of mutations in the Mycobacterium tuberculosis complex and their association with drug resistance, WGS predicted antibiotic resistance in 16 strains. Comparing Drug Susceptibility Testing (DST) and WGS results showed complete concordance across 19 DST tested strains. Conclusion: This study highlights the diversity of M. africanum in Sénégal, with intra-lineage genomic variability and predicted antimicrobial resistance. The presence of synonymous mutations in the absence of resistance-associated variants suggests that WGS–based predictions of drug resistance should be interpreted with caution. Author summary: Senegal is the country where Mycobacterium africanum was first described. Mycobacterium africanum is a Mycobacterium tuberculosis complex pathogen responsible for a significant part of tuberculosis cases in some regions in West Africa, including Sénégal. Here whole genome sequencing of 51 M. africanum isolates recovered from eight regions in Sénégal, unprecedently found that one M. africanum lineage 5 isolate and a novel lineage 6 sub lineage, both participated to geographically structure the population of M. africanum in this country. This observation raises questions regarding weight of the multiple determinants of this situation, opening doors for next works aiming to question the zoonotic and environmental contributions.
SN - 1935-2735
SN - 1935-2727
ER -